Archives

  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2018-07
  • Cy3 TSA Fluorescence System Kit: Benchmarking Signal Ampl...

    2025-12-09

    Cy3 TSA Fluorescence System Kit: Benchmarking Signal Amplification in Fluorescence Microscopy

    Executive Summary: The Cy3 TSA Fluorescence System Kit (SKU: K1051, by APExBIO) is a research-only reagent system designed for ultrasensitive fluorescence detection in IHC, ICC, and ISH workflows. It leverages horseradish peroxidase (HRP)-mediated tyramide deposition, resulting in dense, covalently-bound Cy3 fluorophore localization at target sites (APExBIO product page). This amplification is critical for detecting low-abundance proteins and nucleic acids in fixed tissue or cell samples (Li et al., 2024). Cy3 is excited at 550 nm and emits at 570 nm, compatible with most standard filter sets. The kit's components remain stable for up to two years under specified storage conditions. The system is not intended for diagnostic use.

    Biological Rationale

    Detecting low-abundance proteins, nucleic acids, and regulatory molecules is fundamental in cancer research, neurobiology, and developmental biology (Li et al., 2024). Conventional fluorescence techniques often lack the sensitivity to visualize such targets, especially in complex tissues. Tyramide signal amplification (TSA) exploits the catalytic activity of HRP to locally deposit labeled tyramide, significantly increasing signal intensity without proportionally increasing background noise (see mechanistic analysis). This is vital for studies such as transcriptional regulation in liver cancer, where low-level gene or protein expression must be spatially mapped (Li et al., 2024). The Cy3 TSA Fluorescence System Kit offers a solution by providing robust, reproducible amplification in fixed samples.

    Mechanism of Action of Cy3 TSA Fluorescence System Kit

    The Cy3 TSA Fluorescence System Kit utilizes a multi-step biochemical process:

    • First, a primary antibody binds the target antigen in a fixed sample.
    • An HRP-conjugated secondary antibody is introduced, localizing enzymatic activity to the target site.
    • Upon addition, Cy3-labeled tyramide (dissolved in DMSO) is catalytically converted by HRP into a highly reactive intermediate.
    • This intermediate covalently binds to tyrosine residues on nearby biomolecules, irreversibly anchoring the Cy3 fluorophore at the antigen site.
    • The resulting signal is sharply localized, minimizing background and enabling precise imaging (see detailed workflow).

    Cy3 exhibits a maximal excitation at 550 nm and emission at 570 nm, suitable for standard TRITC filter sets. The kit includes dried Cyanine 3 Tyramide (to dissolve in DMSO), Amplification Diluent, and Blocking Reagent. Storage recommendations are -20°C (protected from light) for tyramide and 4°C for the diluent/blocking reagent, each stable for up to 2 years.

    Evidence & Benchmarks

    • TSA enables detection of proteins and nucleic acids at sub-picomolar concentrations in fixed tissues, outperforming conventional direct immunofluorescence by at least one order of magnitude (Li et al. 2024, https://doi.org/10.1002/advs.202404229).
    • HRP-catalyzed tyramide deposition ensures signal is restricted to the antigen vicinity, resulting in high spatial resolution with low background (Li et al. 2024, https://doi.org/10.1002/advs.202404229).
    • When used in IHC of liver cancer tissues, TSA-based detection revealed expression gradients of SCD1 and FASN undetectable with standard conjugated antibody protocols (Li et al. 2024, https://doi.org/10.1002/advs.202404229).
    • The Cy3 TSA Fluorescence System Kit has been validated for compatibility with both protein and nucleic acid targets in IHC, ICC, and ISH (APExBIO, https://www.apexbt.com/cy3-tsa-fluorescence-system-kit.html).
    • Kit components remain stable for 24 months at recommended storage, enabling reliable longitudinal studies (APExBIO).

    For more on the application in detection of challenging targets, this article details signal amplification in lncRNA and protein studies; the present article refines the mechanistic context with new cancer-relevant benchmarks.

    Applications, Limits & Misconceptions

    The Cy3 TSA Fluorescence System Kit is suitable for:

    • Immunohistochemistry (IHC): Detecting low-abundance proteins in formalin-fixed, paraffin-embedded tissues.
    • Immunocytochemistry (ICC): Amplifying signals in fixed cultured cells, especially where target copy number is low.
    • In Situ Hybridization (ISH): Visualizing rare RNA transcripts, including lncRNAs and microRNAs, in tissue context (see ISH focus).
    • Multiplex Fluorescence Microscopy: Cy3 emission is compatible with standard filters, supporting multicolor experiments.

    The kit is unsuitable for live-cell imaging, diagnostic workflows, or detection of non-tyrosine-rich targets, as the tyramide intermediate requires fixed, permeabilized samples for effective covalent binding.

    Common Pitfalls or Misconceptions

    • Not for Live Cell Imaging: TSA requires fixed, permeabilized samples; live cell compatibility is not supported.
    • Limited to Tyrosine-Containing Environments: Efficient covalent deposition depends on presence of tyrosine residues near the HRP target location.
    • Not Diagnostic: The kit is strictly for research use and not validated for clinical diagnostics.
    • Over-Amplification: Excessive amplification may increase non-specific deposition; titration of reagents is required.
    • Photobleaching: Although Cy3 is relatively photostable, prolonged illumination can reduce fluorescence intensity; minimize exposure.

    Workflow Integration & Parameters

    For optimal results, users should:

    • Fix samples with 4% paraformaldehyde (pH 7.4, 10–20 min at room temperature).
    • Block with supplied reagent (30 min, RT) to minimize background.
    • Incubate with primary antibody (optimized dilution, e.g. 1:100–1:1000, overnight at 4°C).
    • Add HRP-conjugated secondary antibody (1:200–1:1000, 1 hour at RT).
    • Introduce Cy3 tyramide working solution (prepared fresh, 5–10 min at RT in amplification diluent).
    • Wash thoroughly between steps to prevent non-specific amplification.
    • Mount and image using 550 nm excitation/570 nm emission filter sets.

    For a strategic overview of integration into translational research, see this analysis; this article provides additional protocol-level detail and updated stability parameters.

    Conclusion & Outlook

    The Cy3 TSA Fluorescence System Kit from APExBIO provides a validated, high-sensitivity method for amplifying fluorescence signals in fixed biological samples. Its robust mechanism enables detection of proteins and nucleic acids at levels previously undetectable by standard immunofluorescence, empowering research into cancer, developmental biology, and complex tissue analysis. The kit's performance is grounded in peer-reviewed benchmarks and aligns with the latest translational research needs. For more information or to purchase, visit the Cy3 TSA Fluorescence System Kit product page.